Tilray Brands (TLRY) Stock Price, News & Analysis

Company Overview

Tilray Brands, Inc. is a global pioneer in the cultivation, production and distribution of cannabis and hemp-derived products, alongside a growing portfolio of beverage alcohol and wellness offerings. The company’s core operations span medical and adult-use cannabis markets, where it develops and markets a diverse range of products including dried flower, oils, capsules, vapes and topicals. With an integrated supply chain that encompasses breeding, extraction, formulation and packaging, Tilray Brands serves patients, adult-use consumers and retailers across North America, Europe, Latin America and Australia.

Originally founded in 2013 in Nanaimo, British Columbia by a team including Brendan Kennedy, John-Andrew Fowler and David J. Martin, the company went public on the Nasdaq in 2018. In May 2021, Tilray merged with Aphria Inc., creating Tilray Brands, Inc., one of the largest global cannabis companies by production capacity and market reach. The combination brought together Aphria’s leadership in beverage alcohol distribution and Tilray’s international cannabis network, establishing a diversified consumer products company listed on the Nasdaq under the ticker TLRY.

Tilray Brands’ product suite extends beyond cannabis into beverage alcohol through craft beer and spirits brands such as SweetWater Brewing Company, Breckenridge Brewery, Montucky Cold Snacks and a line of low-calorie malt beverages. On the wellness front, the company markets hemp-based foods and nutritional products under brands like Manitoba Harvest. Across all categories, Tilray emphasizes research-driven innovation, quality control and compliance with local regulations to support patient care, adult-use markets and retail partners.

Headquartered in New York, Tilray Brands employs a leadership team led by CEO Irwin D. Simon and supported by executives with deep experience in consumer packaged goods, pharmaceuticals and regulated industries. The company operates production facilities in Canada, Portugal, Germany, Australia and Latin America, and holds licenses to distribute medical and adult-use cannabis in more than 20 countries. Tilray Brands continues to pursue strategic partnerships, research collaborations and targeted acquisitions to drive growth and innovation in emerging regulated markets.

Key Stats

• Today's Range: $0.48 to $0.53
• 50-Day Range: $0.36 to $0.53
• 52-Week Range: $0.35 to $2.15
• Volume: 47.82 million shs
• Average Volume: 29.94 million shs
• Market Capitalization: $506.67 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.92
• Consensus Rating: Hold

Tilray Brands Stock Analysis - MarketRank™

Tilray Brands scored higher than 42% of companies evaluated by MarketBeat, and ranked 667th out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Hold

Consensus Rating

Tilray Brands has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Tilray Brands has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Tilray Brands are expected to grow in the coming year, from ($0.20) to ($0.10) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Tilray Brands is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tilray Brands is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Tilray Brands has a P/B Ratio of 0.12. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

20.00% of the float of Tilray Brands has been sold short.

Short Interest Ratio / Days to Cover

Tilray Brands has a short interest ratio ("days to cover") of 7.8.

Change versus previous month

Short interest in Tilray Brands has recently increased by 8.84%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tilray Brands does not currently pay a dividend.

Dividend Growth

Tilray Brands does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

20.00% of the float of Tilray Brands has been sold short.

Short Interest Ratio / Days to Cover

Tilray Brands has a short interest ratio ("days to cover") of 7.8.

Change versus previous month

Short interest in Tilray Brands has recently increased by 8.84%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.70

News Sentiment

Tilray Brands has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 14 news articles for Tilray Brands this week, compared to 12 articles on an average week.

Search Interest

28 people have searched for TLRY on MarketBeat in the last 30 days. This is an increase of 22% compared to the previous 30 days.

MarketBeat Follows

43 people have added Tilray Brands to their MarketBeat watchlist in the last 30 days. This is an increase of 13% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Tilray Brands insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.60% of the stock of Tilray Brands is held by insiders.

Percentage Held by Institutions

Only 9.35% of the stock of Tilray Brands is held by institutions.

TLRY Stock Analysis - Frequently Asked Questions

How have TLRY shares performed this year?

Tilray Brands' stock was trading at $1.33 at the start of the year. Since then, TLRY shares have decreased by 62.2% and is now trading at $0.5034.

How were Tilray Brands' earnings last quarter?

Tilray Brands, Inc. (NASDAQ:TLRY) issued its earnings results on Tuesday, April, 8th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.06. The business had revenue of $185.78 million for the quarter, compared to the consensus estimate of $213.38 million. Tilray Brands had a negative net margin of 113.85% and a negative trailing twelve-month return on equity of 7.40%.
Read the conference call transcript.

When did Tilray Brands IPO?

Tilray Brands (TLRY) raised $135 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

How do I buy shares of Tilray Brands?

Shares of TLRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tilray Brands own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tilray Brands investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), Humana (HUM), Marinus Pharmaceuticals (MRNS), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 4/08/2025
• Today: 7/08/2025
• Next Earnings (Estimated): 8/04/2025
• Fiscal Year End: 5/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:TLRY
• Previous Symbol: NASDAQ:TLRY
• CIK: 1731348
• Web: www.tilray.com
• Phone: 206-432-9325
• Fax: N/A
• Employees: 2,650
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $1.92
• High Stock Price Target: $3.00
• Low Stock Price Target: $1.00
• Potential Upside/Downside: +280.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$244.98 million
• Net Margins: -113.85%
• Pretax Margin: -115.20%
• Return on Equity: -7.40%
• Return on Assets: -6.02%

Debt

• Debt-to-Equity Ratio: 0.12
• Current Ratio: 2.62
• Quick Ratio: 1.61

Sales & Book Value

• Annual Sales: $788.94 million
• Price / Sales: 0.64
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.14 per share
• Price / Book: 0.12

Miscellaneous

• Outstanding Shares: 1,006,500,000
• Free Float: 1,000,457,000
• Market Cap: $506.67 million
• Optionable: Optionable
• Beta: 1.82